Elekta AB (publ)
STO:EKTA B
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
61.8
87.8794
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Elekta AB (publ)
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | SE |
Market Cap | 24.1B SEK |
Net Margin |
6%
|
Country | US |
Market Cap | 204.9B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 195.2B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 146.7B USD |
Net Margin |
16%
|
Country | US |
Market Cap | 132.6B USD |
Net Margin |
11%
|
Country | IE |
Market Cap | 110.6B USD |
Net Margin |
12%
|
Country | US |
Market Cap | 64.7B USD |
Net Margin |
9%
|
Country | DE |
Market Cap | 55.6B EUR |
Net Margin |
8%
|
Country | CN |
Market Cap | 319.2B CNY |
Net Margin |
34%
|
Country | US |
Market Cap | 41.6B USD |
Net Margin |
74%
|
Country | US |
Market Cap | 37.7B USD |
Net Margin |
9%
|
Elekta AB (publ)
Glance View
Elekta AB operates as a medical technology company. The company is headquartered in Stockholm, Stockholm and currently employs 4,591 full-time employees. The firm offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The firm has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The firm owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Elekta AB (publ)'s most recent financial statements, the company has Net Margin of 6.3%.